Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Keystone Labs Keeps OTC Drugs In Plans After Court Orders Manufacturing Halt

Executive Summary

Keystone Labs agrees to cease manufacturing OTC drugs after repeat GMP violations following a 2013 FDA warning letter, including failure to investigate sources of contamination. Firm says it informed FDA it would outsource OTC product manufacturing and continue making hair and skin care cosmetic formulas.

You may also be interested in...



FDA Consumer Health Product Recalls For May 4-25, 2016

Recalls reported by FDA for OTC drugs, nutritionals and personal care products.

In Brief

New studies from Chanel researchers and Gettysburg College support makeup’s anti-aging effect. More news in brief.

Colgate Says Hello To Subscription-Delivery Wtih Oral Care Line Acquisition

Colgate agrees to purchase Hello Products direct-to-consumer oral care brand, complementing  its Colgate brand and its Tom’s of Maine natural-positioned line. The firm will pay with a combination of cash and debt in the deal expected to close no later than the end of February.

Topics

UsernamePublicRestriction

Register

PS124160

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel